DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20194107

Effect of herbal combination of triphala and garcinia cambogia extracts on anthropometric measurements and lipid profile in high fat diet induced obesity in rats

Vijay Kumar A. N., Vijay Thawani

Abstract


Background: Obesity, occurring at epidemic rates globally, is a major risk factor for DM and CVD. Despite advances in understanding its pathogenesis, the pharmacotherapy for obesity remains limited for achievable weight loss, safety and tolerability of the medicines. Almost all approved medications for long term use in obesity treatment result in health issues. Due to the ADRs associated with many antiobesity drugs, the drug trials have focused on screening herbal medicines that are reportedly used in the treatment of obesity and which have minimal side effects.

Methods: In this study rats were divided into eight groups of six rats each. In the first approach, the rats were first made obese by feeding HFD for three weeks. In the second, treatment with the herbal extracts was given simultaneously with the HFD to the experimental rats. Rat were fed HFD for six weeks along with treatment of herbal extracts and the effect on their body weight, daily food intake and lipid-profile were evaluated.

Results: Results showed that rats fed HFD for a six week period, supplemented with herbal preparations of triphala and G. cambogia presented with significant reduction in body weight, energy intake, and improved the lipid-profile as compared to the rats fed with HFD group.

Conclusions: Our findings suggest that triphala and G. cambogia can counter the effects of HFD intake and have the potential for use as antiobesity agents with desirable body weight, food intake, fluid intake, and lipid-profile modulating properties.


Keywords


Obesity, Triphala, Garcinia cambogia, Body weight, Lipid-profile

Full Text:

PDF

References


Chavarro JE, Toth TL, Wright DL, Meeker JD, Hauser R. Body mass index in relation to semen quality, sperm DNA integrity, and serum reproductive hormone levels among men attending an infertility clinic. Fertil Steril. 2010;93(7):2222-31.

Mayes JS, Watson GH. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev. 2004;5(4):197-216.

Caterson I, Gill T. Obesity:epidemiology and possible prevention. Best Pract Res Clin Endocrinol Metabol. 2003;16(4):595–610.

Abelson P, Kennedy D. The obesity epidemic. Science 2004;304(5676):1413.

Haslam D, James P. Obesity. Lancet. 2005;366(9492):1197–209.

Roos C, Lidfeldt J, Agardh C, Nyberg P, Nerbrand C, Samsioe G, et al. Insulin resistance and self-rated symptoms of depression in Swedish women with risk factors for diabetes:the Women's Health in the Lund Area study. Metabolism. 2007;56(6):825-9.

Roth J, Qiang X, Marbán S, Redelt H, Lowell B. The obesity pandemic: where have we been and where are we going? Obes Res. 2004;12(2):88-101.

Kelly T, Yang W, Chen CS, Reynolds K, He1 J. Global burden of obesity in 2005 and projections to 2030. International J of Obesity. 2008;32(9):1431–7.

Wang Y, Beydoun M, Liang L, Caballero B, Kumanyika S. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring). 2008;16(10):2323-30.

Hill J, Peters J. Environmental contributions to the obesity epidemic. Science. 1998;280(5368):1371-4.

Friedman J. Modern science versus the stigma of obesity. Nat Med. 2004;10(6):563-9.

Knowler W, Pettitt D, Saad M, Bennett P. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev. 1990;6(1):1-27.

Stunkard A, Foch T, Hrubec Z. A twin study of human obesity. JAMA. 1986;256(1):51-4.

Hebebrand J, Friedel S, Schäuble N, Geller F, Hinney A. Perspectives:molecular genetic research in human obesity. Obes Rev. 2003;4(3):139-46.

Walley A, Asher J, Froguel P. The genetic contribution to non-syndromic human obesity. Nat Rev Genet. 2009;10(7):431-42.

Korner J, Woods S, Woodworth K. Regulation of energy homeostasis and health consequences in obesity. Am J Med. 2009;122(4-1):S12-8.

Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 1997;46(1):3-10.

Tan GD, Goossens GH, Humphreys SM, Vidal H, Karpe F. Upper and lower body adipose tissue function:a direct comparison of fat mobilization in humans. Obes Res. 2004;12(1):114-8.

McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 1991;337(8738):382-6.

Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applications. Int J Obes Relat Metab Disord. 2003;27(3):41S-S45.

Anindita D, Sikha B, Biswajit D. Pharmacological activities of Baheda (Terminalia bellerica):A review. J of Pharmacognosy Phytochem. 2016;5(1):194-7.

Yokozawa T, Kim HY, Kim HJ, Okubo T, Chu DC, Juneja LR. Amla(Emblica Officinalis Gaertn.) prevents dyslipidaemia and oxidative stress in the ageing process. Br J Nutr. 2007;97(6):1187-95.

Kamali SH, Khalaj AR, Shirin HR, Esfehani MM, Kamalinejad M, Larijani B. A systematic review of the antioxidant, anti-diabetic, and anti-obesity effects and safety of triphala herbal formulation. 2013;7(14):831-44.

Juang LJ, Sheu SJ, Lin TC. Determination of hydrolyzable tannins in the fruit of Terminalia chebula Retz. by high-performance liquid chromatography and capillary electrophoresis. J Sep Sci. 2004;27(9):718-724.

Chattopadhyay RR, Bhattacharyya SK. Plant Review Terminalia chebula. Pharmacognos. Rev. 2007;23:145-50.

Kirby J, Philip N, Howles Y. Hypolipidemic effect of triphala in experimentally induced hypercholes-teremic rats. J Lipid Res. 2004;45(1):89-98.

Ferrara L. The garcinia cambogia in phytotreatment of obesity:activities of the hydroxycitric acid. European Scientific J. 2014;10(21):291-301.

MaruthappanVK, Sakthi S, Hypolipedimic activity A Haritaki in atherogenic diet induced hyperlypidemic rats. J. Adv Pharm tech Res. 2010;1(2):229-35.

Sergio W. A natural food, the malabar tamarind, may be effective in the treatment of obesity. Med Hypotheses. 1988;27(1):39–40.

Lowenstein JM. Effect of (–)-hydroxycitrate on fatty acid synthesis by rat liver in vivo. J Biol Chem. 1971;246(3):629–32.

Ohia SE. Safety and mechanism of appetite suppression by a novel hydroxycitric acid extract (HCA-SX). Mol Cell Biochem. 2002;238(1-2):89-103.

Dagogo JS. Human leptin regulation and promise in pharmacotherapy. Curr Drug Targets. 2001;2:181–95.

Kizhakkeveettil A, Jayagopal PS, Rose KK. Hypercholesterolemia and Ayurvedic Medicine:A Case Report. Topics in Integrative Health Care. 2011;2(2).

Murali YK, Anand P, Tandon V, Singh R, Chandra R, Murthy PS. Long-term effects of Terminalia chebula Retz. on hyperglycemia and associated hyperlipidemia, tissue glycogen content and in vitro release of insulin in streptozotocin induced diabetic rats. Exp Clin Endocrinol Diabetes. 2007;115(10):641-6.

Vani T, Rajani M, Sarkar S, Shishoo CJ. Antioxidant properties of the ayurvedic formulation triphala and its constituents International. J Pharmacognosy. 1997;35(5):313-7.

Cabrera C, Artacho R, Gimenez R. Beneficial Effects of Green Tea – A Review. J. Am. Coll. Nutr. 2006;25(2):79-99.

Wolfram S, Wang Y, Thielecke F. Anti-obesity Effects of Green Tea:From Bedside to Bench. Mol. Nutr. Food Res. 2006;50(2):176-87.

Thielecke F, Boschmann M. The Potential Role of Green Tea Catechins in the Prevention of Metabolic Syndrome – A Review. Phytochem. 2009;70(1):11-24.

Li HB, Jiang Y, Wong CC, Cheng KW, Chen F. Evaluation of Two Methods for the Extraction of Antioxidants from Medicinal Plants. Anal Bioanal Chem. 2007;388(2):483-8.